Heart Matters

Since cardiovascular disease is one of the leading causes of death in the U.S., cardiology physicians are continuously working to better understand this common disease and to help patients improve their heart health. And here to assist cardiology physicians in this mission is Heart Matters, a series dedicated to covering essential strategies and research efforts focusing on all types of heart problems, including coronary artery diseases, heart attacks, high cholesterol, high blood pressure, and more.

So whether you’re looking for ways to improve heart health or catch up on the latest cardiology research, you never have to worry about missing a beat thanks to Heart Matters.

658

LikeLikedUnlike

61-75 of 248

Assessing the Effectiveness of Lp(a) Lowering Therapies in Clinical Trials
Heart Matters
Assessing the Effectiveness of Lp(a) Lowering Therapies in Clinical Trials
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Alan S. Brown, MD, FACC, FAHA, FNLA
  Peer
Genetic Guidance in Action: A Study for Selecting Oral P2Y Inhibitor
Heart Matters
Genetic Guidance in Action: A Study for Selecting Oral P2Y Inhibitor
Stanford Surgeons Perform First Beating-Heart Procedure
Heart Matters
Stanford Surgeons Perform First Beating-Heart Procedure
- Javed Butler, MD
  Peer
- John W. MacArthur
  Peer
Treating Tricuspid Valve Regurgitation With Novel Replacement Device
Heart Matters
Treating Tricuspid Valve Regurgitation With Novel Replacement Device
- Javed Butler, MD
  Peer
- Pedro A Villablanca Spinetto, MD
  Peer
Exploring the Use of AI to Detect HFpEF
ACC Action Center
Exploring the Use of AI to Detect HFpEF
- Patricia A. Pellikka, M.D.
  Peer
Cardio-Oncology: Key Clinical Data from ACC.23
ACC Action Center
Cardio-Oncology: Key Clinical Data from ACC.23
- Ana Barac, MD, PhD
  Peer
advertisement
4D Holographic Technology Aids Heart Procedure
Heart Matters
4D Holographic Technology Aids Heart Procedure
Managing Dyslipidemia With Recently Approved Drug
Heart Matters
Managing Dyslipidemia With Recently Approved Drug
The Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team
ACC Action Center
The Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team
- Javed Butler, MD
  Peer
- Ana Barac, MD, PhD
  Peer
The STELLAR Trial: Key Data on Sotatercept for PAH
ACC Action Center
The STELLAR Trial: Key Data on Sotatercept for PAH
- Marius M. Hoeper, MD
  Peer
Insights on Statin Therapy & LDL Cholesterol from the CLEAR Outcomes Trial
ACC Action Center
Insights on Statin Therapy & LDL Cholesterol from the CLEAR Outcomes Trial
- Kausik Ray, MBChB, MD, MPhil
  Peer
Highlights from Day 3 of ACC.23
ACC Action Center
Highlights from Day 3 of ACC.23
advertisement
Social Media & Heart Health: Insights from ACC.23
ACC Action Center
Social Media & Heart Health: Insights from ACC.23
Exploring Clinical Data From Day 1 of ACC.23
ACC Action Center
Exploring Clinical Data From Day 1 of ACC.23
Developments in Cardiology from Day 2 of ACC.23
ACC Action Center
Developments in Cardiology from Day 2 of ACC.23